v3.25.2
Condensed Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Mar. 05, 2025
Balance, shares at Mar. 05, 2025      
Sale of 638,000 Private Placement Units [1],[2] $ 604 24,396 25,000
Sale of private placement units , shares [1],[2] 6,037,500      
Net Income (46,095) (46,095)
Balance at Mar. 31, 2025 $ 604 24,396 (46,095) (21,095)
Balance, shares at Mar. 31, 2025 6,037,500      
Balance at Mar. 05, 2025
Balance, shares at Mar. 05, 2025      
Net Income         828,395
Balance at Jun. 30, 2025 $ 64 $ 604 (7,934,461) (7,933,793)
Balance, shares at Jun. 30, 2025 638,000 6,037,500      
Balance at Mar. 31, 2025 $ 604 24,396 (46,095) (21,095)
Balance, shares at Mar. 31, 2025 6,037,500      
Sale of 638,000 Private Placement Units $ 64 6,379,936 6,380,000
Sale of private placement units , shares 638,000        
Net Income 874,490 874,490
Accretion for Class A ordinary shares to redemption amount (8,295,814) (8,762,856) (17,058,670)
Fair Value of Public Warrants at issuance 1,907,850 1,907,850
Allocated value of transaction costs to Class A shares (141,108) (141,108)
Share-based compensation to director nominees 124,740 124,740
Balance at Jun. 30, 2025 $ 64 $ 604 $ (7,934,461) $ (7,933,793)
Balance, shares at Jun. 30, 2025 638,000 6,037,500      
[1] On May 2, 2025, and on May 12, 2025, the Company effected a share capitalization pursuant to which the Company issued an additional 1,725,000 Founder Shares to the Sponsor and the independent director nominees for no additional consideration, resulting in an aggregate of 6,037,500 Founder Shares issued and outstanding. All share and per share data is retroactively presented (see Note 4 and Note 6).
[2] On May, 14, 2025, the underwriters exercised their over-allotment in full as part of the closing of the Initial Public Offering. As such, the 787,500 Founder Shares are no longer subject to forfeiture (See Note 4).